Review
doi: 10.1016/j.coph.2004.03.005.
Inhibition of IL-6 for the treatment of inflammatory diseases
Affiliations
- PMID: 15251133
- DOI: 10.1016/j.coph.2004.03.005
Item in Clipboard
Review
Inhibition of IL-6 for the treatment of inflammatory diseases
Curr Opin Pharmacol.
2004 Aug.
Abstract
Interleukin-6 (IL-6) is a pleiotropic cytokine with various biological activities. Deregulated overproduction of IL-6 has been found to play pathological roles in chronic inflammatory diseases such as rheumatoid arthritis, Castleman's disease, juvenile idiopathic arthritis and Crohn's disease. Humanized anti-IL-6 receptor antibody has been developed as a therapeutic agent for these diseases, and therapeutic benefits have been revealed in clinical studies.
Similar articles
-
Interleukin 6: from bench to bedside.Nat Clin Pract Rheumatol. 2006 Nov;2(11):619-26. doi: 10.1038/ncprheum0338. Nat Clin Pract Rheumatol. 2006. PMID: 17075601 Review.
-
Clinical studies in patients with Castleman's disease, Crohn's disease, and rheumatoid arthritis in Japan.Clin Rev Allergy Immunol. 2005 Jun;28(3):221-30. doi: 10.1385/CRIAI:28:3:221. Clin Rev Allergy Immunol. 2005. PMID: 16129906 Review.
-
The value of blocking IL-6 outside of rheumatoid arthritis: current perspective.Curr Opin Rheumatol. 2011 May;23(3):273-7. doi: 10.1097/BOR.0b013e3283456797. Curr Opin Rheumatol. 2011. PMID: 21427577 Review.
-
Interleukin-6 as a therapeutic target in candidate inflammatory diseases.Clin Pharmacol Ther. 2010 Apr;87(4):483-7. doi: 10.1038/clpt.2009.313. Epub 2010 Feb 24. Clin Pharmacol Ther. 2010. PMID: 20182422 Review.
-
[Anti-IL-6 receptor antibody].Nihon Rinsho. 2005 May;63 Suppl 5:723-7. Nihon Rinsho. 2005. PMID: 15954436 Review. Japanese. No abstract available.
Cited by
-
Serum interleukin-6 concentration in patients with pemphigus.Dermatol Reports. 2024 Feb 1;16(2):9868. doi: 10.4081/dr.2024.9868. eCollection 2024 Jun 14. Dermatol Reports. 2024. PMID: 38957630 Free PMC article.
-
Enhancement of anti-inflammatory tendency by SB203580, p38alpha specific inhibitor, in human fibroblast-like synoviocyte cell line, MH7A.Rheumatol Int. 2006 Sep;26(11):972-8. doi: 10.1007/s00296-006-0109-4. Epub 2006 Mar 11. Rheumatol Int. 2006. PMID: 16532349
-
IL-31-IL-31R interactions limit the magnitude of Th2 cytokine-dependent immunity and inflammation following intestinal helminth infection.J Immunol. 2009 May 15;182(10):6088-94. doi: 10.4049/jimmunol.0802459. J Immunol. 2009. PMID: 19414760 Free PMC article.
-
Molecular weight dependent glucose lowering effect of low molecular weight Chitosan Oligosaccharide (GO2KA1) on postprandial blood glucose level in SD rats model.Int J Mol Sci. 2013 Jul 9;14(7):14214-24. doi: 10.3390/ijms140714214. Int J Mol Sci. 2013. PMID: 23839092 Free PMC article.
-
Generation of a transgenic mouse line for conditional expression of human IL-6.Exp Anim. 2016 Nov 1;65(4):455-463. doi: 10.1538/expanim.16-0043. Epub 2016 Jun 28. Exp Anim. 2016. PMID: 27349442 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
